APA (7th ed.) Citation

MM, S., MM, S., MA, S., NZ, A., MA, A., & HAA, E. (2026). Evaluation of serum human galectin 3 as a marker of activity in inflammatory bowel disease in comparison to fecal calprotectin. The Egyptian journal of immunology, 33(3), 65. https://doi.org/10.55133/eji.330307

Chicago Style (17th ed.) Citation

MM, Salama, Sayed MM, Saad MA, Ali NZ, Abdelwahed MA, and Elessawy HAA. "Evaluation of Serum Human Galectin 3 as a Marker of Activity in Inflammatory Bowel Disease in Comparison to Fecal Calprotectin." The Egyptian Journal of Immunology 33, no. 3 (2026): 65. https://doi.org/10.55133/eji.330307.

MLA (9th ed.) Citation

MM, Salama, et al. "Evaluation of Serum Human Galectin 3 as a Marker of Activity in Inflammatory Bowel Disease in Comparison to Fecal Calprotectin." The Egyptian Journal of Immunology, vol. 33, no. 3, 2026, p. 65, https://doi.org/10.55133/eji.330307.